Search for: "Finnegan, Henderson, Farabow, Garrett, "
Results 81 - 100
of 309
Sort by Relevance
|
Sort by Date
27 May 2018, 8:42 pm
Tull of Finnegan Henderson Farabow Garrett & Dunner will guide counsel for companies in the medical device industry on protecting software as a medical device (SaMD), and discuss the new FDA rules regulating SaMD and how to leverage IP law to protect SaMD. [read post]
19 May 2018, 9:00 pm
Bell and Doris Johnson Hines of Finnegan Henderson Farabow Garrett & Dunner will guide IP counsel on functional claiming in software patents and USPTO prosecution, examine recent court treatment, and explain how to navigate the issue of functionality given the uncertainties in the prosecution and litigation contexts. [read post]
12 May 2018, 9:24 pm
Rudolph of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel on two recent Supreme Court patent decisions. [read post]
12 May 2018, 9:22 pm
Rudolph of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to counsel on the impact of the Federal Circuit's decision in Travel Sentry Inc. v. [read post]
5 May 2018, 8:45 pm
O’Connor, and Sanya Sukduang of Finnegan Henderson Farabow Garrett & Dunner will guide patent counsel on the essentials of patent exclusivity that are in critical need of independent checking, and discuss crucial health checks on U.S. patent exclusivity for biologics in Phase II efficacy trials and proceedings through large scale randomized Phase III clinical trials, submission of the BLA, and subsequent approval and marketing.... [read post]
21 Apr 2018, 6:16 pm
Swan of Finnegan Henderson Farabow Garrett & Dunner will guide patent counsel on supplemental examination requests generally and specific to chemical patents, examine the supplemental examination successes and its limitations, and provide insight on the strategic use of supplemental examinations. [read post]
14 Apr 2018, 7:58 pm
Murphy of Finnegan Henderson Farabow Garrett & Dunner will provide guidance for patent counsel on identifying and determining inventorship, offer best practices for correcting errors regarding inventorship, offer perspectives gained from working with the AIA since it was passed, and outline lessons from recent court decisions. [read post]
7 Apr 2018, 8:16 pm
Mulcahy of Finnegan Henderson Farabow Garrett & Dunner will examine the latest revisions to the USPTO Manual of Patent Examining Procedure (MPEP), including a discussion of patent eligibility, duty to disclose, and other changes to the MPEP, and explore the impact on patent prosecution and provide best practices for applying the new guidance. [read post]
17 Mar 2018, 8:47 pm
The John Marshall Law School Center for Intellectual Property, Information & Privacy Law will be hosting Donald Dunner of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, who will be presenting a CLE course entitled "Court of Appeals for the Federal Circuit Practice & Procedure" from 9:00 am to 4:30 pm on April 7, 2018 and April 14, 2018 at the John Marshall Law School in Chicago, IL. [read post]
17 Mar 2018, 8:40 pm
Tull of Finnegan Henderson Farabow Garrett & Dunner will guide counsel for companies in the medical device industry on protecting software as a medical device (SaMD), and also discuss the new FDA rules regulating SaMD and how to leverage IP law to protect SaMD. [read post]
3 Mar 2018, 9:36 pm
Sweet of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel on leveraging interviews with U.S. [read post]
24 Feb 2018, 9:07 pm
Irving of and Doris Johnson Hines of Finnegan Henderson Farabow Garrett & Dunner and Daniel G. [read post]
17 Feb 2018, 8:15 pm
Murphy of Finnegan Henderson Farabow Garrett & Dunner will provide guidance for patent counsel on identifying and determining inventorship, offer best practices for correcting errors regarding inventorship, and offer perspectives gained from working with the AIA since it was passed—and outline lessons from recent court decisions. [read post]
17 Feb 2018, 8:11 pm
Livingstone of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel on the essentials of patent exclusivity that are in critical need of independent checking, and discuss crucial health checks on U.S. patent exclusivity for small molecules in Phase... [read post]
10 Feb 2018, 9:57 pm
Totten of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel on identifying and addressing patent infringement risk in the product development process. [read post]
3 Feb 2018, 8:58 pm
Jorge Goldstein of Sterne, Kessler, Goldstein & Fox, PLLC; Brian Kacedon of Finnegan, Henderson, Farabow, Garrett & Dunner LLP; and William Krovatin of Merck & Co Inc. will discuss strategies and recent court cases that involve: • Staking out the claim that a sale is not an "authorized sale" — Chrimar v. [read post]
20 Jan 2018, 9:50 pm
Murphy of Finnegan Henderson Farabow Garrett & Dunner, and Amelia Feulner Baur of McNeill Baur will provide guidance to patent counsel on the impact of recent Federal Circuit and PTAB case law on daily patent practice, and offer best practices to navigate pre- and post-issuance scrutiny for compliance with 35 U.S.C. [read post]
13 Jan 2018, 8:51 pm
Diner and Carla Mouta-Bellum of Finnegan Henderson Farabow Garrett & Dunner, Amy Feng of Wu Feng & Zhang, and Hazel Ford of Finnegan Europe will provide guidance to patent counsel on overcoming the challenges of obviousness in biologics patent claims in the U.S., Europe, and China; will examine the similarities and differences between claim types that have the best chance of success; and will discuss recent case... [read post]
4 Jan 2018, 8:59 am
Thayer, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Mercedes K. [read post]
30 Dec 2017, 8:39 pm
MacAlpine of Finnegan Henderson Farabow Garrett & Dunner will provide patent counsel with an in-depth review of the pros and cons of using reissue, offer their experiences, perspectives and best practices on the strategic use of patent reissue to correct errors. [read post]
